TWM582394U - Comfrey dripping pill particle structure - Google Patents

Comfrey dripping pill particle structure Download PDF

Info

Publication number
TWM582394U
TWM582394U TW108203661U TW108203661U TWM582394U TW M582394 U TWM582394 U TW M582394U TW 108203661 U TW108203661 U TW 108203661U TW 108203661 U TW108203661 U TW 108203661U TW M582394 U TWM582394 U TW M582394U
Authority
TW
Taiwan
Prior art keywords
comfrey
particles
extract
granule
granules
Prior art date
Application number
TW108203661U
Other languages
Chinese (zh)
Inventor
陳昱圻
Original Assignee
陳昱圻
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 陳昱圻 filed Critical 陳昱圻
Priority to TW108203661U priority Critical patent/TWM582394U/en
Publication of TWM582394U publication Critical patent/TWM582394U/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

一種紫草滴丸微粒結構,用以解決習知的紫草保健品分散性及安定性不佳的問題。係包含:一本體;及數個紫草顆粒,各該紫草顆粒由該本體包覆,使該數個紫草顆粒分散於該本體中,各該紫草顆粒為包含紫草活性成分的分子顆粒、膠體顆粒或微晶顆粒。A comfrey drip pellet structure for solving the problem of poor dispersion and stability of the comfrey health care products. The method comprises: a body; and a plurality of comfrey particles, each of the comfrey particles being coated by the body, wherein the plurality of comfrey particles are dispersed in the body, and each comfrey particle is a molecule containing an active ingredient of comfrey Granules, colloidal particles or microcrystalline particles.

Description

紫草滴丸微粒結構Psyllium granules

本創作係關於一種保健用品,尤其是一種具有良好分散性及安定性的紫草滴丸微粒結構。This creation is about a health care product, especially a comfrey pellet structure with good dispersibility and stability.

紫草泛指硬紫草( Lithospermum erythrorhizonSieb. et Zucc)及軟紫草( Arnebia euchroma(Royle)Johnst.)等紫草科的多年生草本植物,近年來,藥理研究證實紫草的活性成分具有抗菌消炎、促進傷口癒合、抗癌、保肝、抗凝血、護眼及調節免疫等多種作用,可以滿足人體的各種保健需求,故已有許多的保健用品業者投入紫草保健品的研發。 Perilla is a perennial herb of the comfrey family such as Lithospermum erythrorhizon Sieb. et Zucc and Arnebia euchroma (Royle) Johnst. In recent years, pharmacological studies have confirmed that the active ingredients of comfrey have antibacterial properties. Anti-inflammatory, promote wound healing, anti-cancer, liver protection, anti-coagulation, eye protection and immune regulation, can meet the various health needs of the human body, so many health care products have invested in the development of comfrey health products.

紫草的活性成分(例如紫草素,shikonin)為疏水性物質,在水中的分散性低而造成溶解度不佳,造成人體的可吸收率及生體利用率(bioavailability)不佳。此外,紫草的活性成分也會因為光照發生光裂解(photodegradation),造成變質等狀況的發生,因此具有安定性不佳的問題。The active ingredient of comfrey (for example, shikonin) is a hydrophobic substance, and its dispersibility in water is low, resulting in poor solubility, resulting in poor absorbability and bioavailability of the human body. In addition, the active ingredient of comfrey also causes photodegradation due to light, which causes deterioration and the like, and thus has a problem of poor stability.

有鑑於此,仍需開發一種新的紫草保健品具有良好的分散性及安定性,則可以提升紫草保健品的保存期限,並使紫草的活形成分可以被人體有效的吸收及利用。In view of this, it is still necessary to develop a new comfrey health product with good dispersibility and stability, which can improve the shelf life of comfrey health products, and enable the active formation of comfrey to be effectively absorbed and utilized by the human body. .

為解決上述問題,本創作的目的是提供一種紫草滴丸微粒結構,具有良好的分散性及安定性者。In order to solve the above problems, the purpose of the present invention is to provide a comfrey droplet structure structure, which has good dispersibility and stability.

本創作的次一目的是提供一種紫草滴丸微粒結構,係具有良好的護眼效果者。The second purpose of this creation is to provide a comfrey pellet structure which has a good eye protection effect.

本創作的又一目的是提供一種紫草滴丸微粒結構,係具有良好的抗菌消炎效果者。Another object of the present invention is to provide a comfrey drip pellet structure which has a good antibacterial and anti-inflammatory effect.

本創作的再一目的是提供一種紫草滴丸微粒結構,係可以提升保存期限者。A further object of the present invention is to provide a comfrey pellet structure which is capable of improving shelf life.

本創作全文所記載的元件及構件使用「一」或「一個」之量詞,僅是為了方便使用且提供本創作範圍的通常意義;於本創作中應被解讀為包括一個或至少一個,且單一的概念也包括複數的情況,除非其明顯意指其他意思。The use of the terms "a" or "an" or "an" or "an" or "an" or "an" The concept also includes the plural, unless it clearly means other meanings.

本創作的紫草滴丸微粒結構,包含:一本體;及數個紫草顆粒,各該紫草顆粒由該本體包覆,使該數個紫草顆粒分散於該本體中,各該紫草顆粒為包含紫草活性成分的分子顆粒、膠體顆粒或微晶顆粒The comfrey pellet structure of the present invention comprises: a body; and a plurality of comfrey particles, each of which is covered by the body, so that the plurality of comfrey particles are dispersed in the body, each comfrey The particles are molecular particles, colloidal particles or microcrystalline particles containing the active constituents of comfrey

據此,本創作的紫草滴丸微粒結構,由於該本體可以包覆該數個紫草顆粒,使該數個紫草顆粒可以與外界的溫度、空氣、光線、水氣等環境因子隔絕,進而可以減少該數個紫草顆粒的活性成分變質等問題的發生,具有提升安定性的功效;另一方面,由於各該紫草顆粒可以為分子顆粒、膠體顆粒或微晶顆粒,且該數個紫草顆粒分散於該本體中,藉此,該數個紫草顆粒可以在該本體溶解後釋出,且溶解狀態的該基質可以減少該數個紫草顆粒的聚集,以維持該數個紫草顆粒的分散狀態,進而增加溶解度,具有提升紫草活性成分的人體吸收率及生體利用率的功效。Accordingly, the lavender droplets of the present invention can be coated with the plurality of comfrey particles, so that the comfrey particles can be isolated from environmental factors such as temperature, air, light, moisture and the like. Further, the occurrence of problems such as deterioration of active ingredients of the plurality of comfrey particles can be reduced, and the effect of improving stability can be improved; on the other hand, each of the comfrey particles can be molecular particles, colloidal particles or microcrystalline particles, and the number The comfrey particles are dispersed in the body, whereby the plurality of comfrey particles can be released after the body is dissolved, and the matrix in a dissolved state can reduce the aggregation of the plurality of comfrey particles to maintain the plurality of The dispersing state of the comfrey granules, thereby increasing the solubility, has the effect of improving the body absorption rate and the utilization rate of the living body of the comfrey active ingredient.

本創作的紫草滴丸微粒結構還可以另包含數個護眼顆粒,該數個護眼顆粒選自由一維生素A顆粒、一葉黃素顆粒、一玉米黃素顆粒、一蝦紅素顆粒、一藻紅素顆粒、一茄紅素顆粒、一花青素顆粒、一黑醋粟萃取物顆粒、一小米草萃取物顆粒、一山桑子萃取物顆粒、一黃耆萃取物顆粒、一決明子萃取物顆粒、一菊花萃取物顆粒及一枸杞萃取物顆粒所組成之群組。如此,該數個護眼顆粒與該數個紫草顆粒的活性成分可以產生協同作用,具有提升該紫草滴丸微粒結構護眼作用的功效。The comfrey droplet structure of the present invention may further comprise a plurality of eye protection particles selected from the group consisting of a vitamin A granule, a lutein granule, a zeaxanthin granule, a lycopene granule, and a Lycopene granules, lycopene granules, monocyanidin granules, melamine extract particles, a millet grass extract granule, a mulberry extract granule, a xanthine extract granule, a cassia extract A group consisting of granules, a chrysanthemum extract granule and a sputum extract granule. In this way, the plurality of eye-protecting particles and the active ingredients of the plurality of comfrey particles can have a synergistic effect, and have the effect of enhancing the eye-protecting effect of the comfrey droplets.

本創作的紫草滴丸微粒結構還可以另包含數個抗菌消炎顆粒,該數個抗菌消炎顆粒選自由一金銀花萃取物顆粒、一當歸萃取物顆粒、一牛蒡萃取物顆粒、一藿香萃取物顆粒、一穿心蓮萃取物顆粒、一茵陳萃取物顆粒、一黃連萃取物顆粒、一香薷萃取物顆粒、一龍膽草萃取物顆粒、一白鶴靈芝草萃取物顆粒、一蒲公英萃取物顆粒、一薑黃萃取物顆粒、一甘草萃取顆粒及一紫蘇萃取物顆粒所組成之群組。如此,該數個抗菌消炎顆粒與該數個紫草顆粒的活性成分可以產生協同作用,具有提升該紫草滴丸微粒結構抗菌消炎作用的功效。The comfrey pellet structure of the present invention may further comprise a plurality of antibacterial anti-inflammatory particles selected from the group consisting of a honeysuckle extract granule, an angelica extract granule, a burdock extract granule, and a musk extract. Granules, an andrographis extract granules, a sinensis extract granule, a berberine extract granule, a citron extract granule, a gentian extract granule, a white crane ganoderma lucidum extract granule, a dandelion extract granule, A group consisting of turmeric extract granules, licorice extract granules and a perilla extract granule. Thus, the plurality of antibacterial anti-inflammatory particles and the active ingredients of the plurality of comfrey particles can produce a synergistic effect, and have the effect of enhancing the antibacterial and anti-inflammatory action of the comfrey droplet structure.

本創作的紫草滴丸微粒結構還可以另包含一外膜層,該外膜層包覆於該本體的外表面。如此,該外膜層可以使該本體隔絕於外界的溫度、空氣、光線或水氣等環境因子,而可以減少該本體發生變質等問題,具有提升該紫草滴丸微粒結構的保存期限的功效。The comfrey pellet structure of the present invention may further comprise an outer film layer coated on the outer surface of the body. In this way, the outer film layer can isolate the body from external environmental factors such as temperature, air, light or moisture, and can reduce the problem of deterioration of the body, and has the effect of improving the shelf life of the comfrey droplet structure. .

為讓本創作之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本創作之較佳實施例,並配合所附圖式,作詳細說明如下:In order to make the above and other objects, features and advantages of the present invention more comprehensible, the preferred embodiments of the present invention are described in detail below with reference to the accompanying drawings.

請參照第1圖所示,其係本創作紫草滴丸微粒結構的第一實施例,係包含一本體1及數個紫草顆粒2,該數個紫草顆粒2分散於該本體1中,使該本體1可以包覆該數個紫草顆粒2。Referring to FIG. 1 , a first embodiment of the comfrey granule structure is composed of a body 1 and a plurality of comfrey particles 2 dispersed in the body 1 . The body 1 can coat the plurality of comfrey particles 2.

詳言之,該本體1係可以由一基質所形成,舉例來說,該基質可以是一明膠、一聚乙二醇(PEG)或一聚維酮(PVP)等水溶性的基質;或者可以是一蜂蠟、一硬脂酸或一氫化植物油等非水溶性的基質;該基質亦可以是水溶性的基質及非水溶性的基質混合形成的一混合基質。較佳地,該基質可以是水溶性的基質,如此,當使用者服用該紫草滴丸微粒結構時,該本體1可以由唾液快速溶解,使該數個紫草顆粒2的活性成分可以快速釋出,以由口腔黏膜直接吸收。該本體1係可以由該基質形成球狀、橢圓球狀、長條狀或水滴狀等各種幾何形狀,在本實施例中,係以球狀予以說明,但不以此為限。In detail, the body 1 may be formed of a matrix, for example, the matrix may be a water-soluble matrix such as gelatin, polyethylene glycol (PEG) or povidone (PVP); It is a water-insoluble substrate such as beeswax, monostearic acid or hydrogenated vegetable oil; the matrix may also be a mixed matrix formed by mixing a water-soluble matrix and a water-insoluble matrix. Preferably, the substrate may be a water-soluble matrix, such that when the user takes the comfrey pellet structure, the body 1 can be rapidly dissolved by saliva, so that the active ingredients of the several comfrey particles 2 can be quickly Released to be directly absorbed by the oral mucosa. The body 1 can be formed into a spherical shape, an elliptical shape, an elongated shape, or a drop shape by the matrix. In the present embodiment, it is described in a spherical shape, but is not limited thereto.

各該紫草顆粒2可以為包含紫草活性成分的分子顆粒、膠體顆粒或微晶顆粒等,且該數個紫草顆粒2可以為粒徑大小相同或不同的顆粒,使該數個紫草顆粒2可以分散於該本體1中。各該紫草顆粒2可以由一包含紫草活性成分的物質所形成,舉例來說,各該紫草顆粒2係可以由紫草粉末、紫草浸泡液或是紫草萃取物等所製成,如此,各該紫草顆粒2可以含有紫草的活性成分,而具有多種保健作用。Each of the comfrey particles 2 may be a molecular particle, a colloidal particle or a microcrystalline particle containing the active ingredient of the comfrey, and the plurality of comfrey particles 2 may be particles having the same or different particle sizes, so that the plurality of comfrey The particles 2 can be dispersed in the body 1. Each of the comfrey particles 2 may be formed of a substance containing a comfrey active ingredient. For example, each of the comfrey particles 2 may be made of comfrey powder, comfrey soaking liquid or comfrey extract. Thus, each of the comfrey particles 2 may contain an active ingredient of comfrey, and has various health effects.

值得一提的是,本創作的紫草滴丸微粒結構係可以藉由固體分散方法所製成,詳言之,製造者可以先藉由加熱等方法,使該基質可以呈現液態;續將該數個紫草顆粒2均勻地混合入液態的該基質,使該數個紫草顆粒2分散於該基質中,而得一混合物;接著,將該混合物滴入一冷凝液中,由於該基質不會溶解於該冷凝液中,使該基質會於該冷凝液中冷卻凝固而成型出具有前述型態的該本體1,如此,該數個紫草顆粒2即可以由固體的該本體1所包覆,並且分散於該本體1中,使該混合物可以形成該紫草滴丸微粒結構。It is worth mentioning that the comfrey pellet structure of the present invention can be made by a solid dispersion method. In detail, the manufacturer can first make the substrate liquid by heating or the like; a plurality of comfrey particles 2 are uniformly mixed into the liquid substrate, and the plurality of comfrey particles 2 are dispersed in the matrix to obtain a mixture; then, the mixture is dropped into a condensate, since the matrix is not Dissolving in the condensate, the substrate is cooled and solidified in the condensate to form the body 1 having the foregoing type, and thus, the plurality of comfrey particles 2 can be covered by the solid body 1 Covered and dispersed in the body 1 such that the mixture can form the comfrey pellet structure.

此外,該紫草滴丸微粒結構還可以另包含數個護眼顆粒3,該數個護眼顆粒3可以與該數個紫草顆粒2同時混入該基質中,使該數個護眼顆粒3可以分散於該本體1中。該數個護眼顆粒3可以選自維生素A顆粒、葉黃素顆粒、玉米黃素顆粒、蝦紅素(astaxanthin)顆粒、藻紅素顆粒、茄紅素顆粒、花青素(anthocyanidin)顆粒、黑醋粟萃取物顆粒、小米草萃取物顆粒、山桑子萃取物顆粒、一黃耆萃取物顆粒、一決明子萃取物顆粒、一菊花萃取物顆粒及枸杞萃取物顆粒所組成之群組。如此,該數個護眼顆粒3與該數個紫草顆粒2的活性成分可以產生協同作用,進而可以提升該紫草滴丸微粒結構的護眼作用。In addition, the comfrey pellet structure may further comprise a plurality of eye protection particles 3, and the plurality of eye protection particles 3 may be mixed into the matrix simultaneously with the plurality of comfrey particles 2, so that the plurality of eye protection particles 3 It can be dispersed in the body 1. The plurality of eye protection particles 3 may be selected from the group consisting of vitamin A particles, lutein particles, zeaxanthin particles, astaxanthin particles, phycoerythrin particles, lycopene particles, anthocyanidin particles, A group consisting of vinegar millet extract granules, millet grass extract granules, mulberry extract granules, a xanthine extract granules, a cassia seed extract granule, a chrysanthemum extract granule, and sputum extract granules. Thus, the plurality of eye protection particles 3 and the active ingredients of the plurality of comfrey particles 2 can synergistically act to enhance the eye protection effect of the comfrey droplet structure.

另一方面,本創作的紫草滴丸微粒結構還可以另包含數個抗菌消炎顆粒4,同樣地,該數個抗菌消炎顆粒4可以與該數個紫草顆粒2同時混入該基質中,使該數個抗菌消炎顆粒4可以分散於該本體1中。該數個抗菌消炎顆粒4可以選自金銀花萃取物顆粒、當歸萃取物顆粒、牛蒡萃取物顆粒、藿香萃取物顆粒、穿心蓮萃取物顆粒、茵陳萃取物顆粒、黃連萃取物顆粒、香薷萃取物顆粒、龍膽草萃取物顆粒、白鶴靈芝草萃取物顆粒、蒲公英萃取物顆粒、薑黃萃取物顆粒、甘草萃取顆粒及紫蘇萃取物顆粒所組成之群組,如此,該數個抗菌消炎顆粒4與該數個紫草顆粒2的活性成分可以產生協同作用,進而可以提升該紫草滴丸微粒結構的抗菌消炎作用。On the other hand, the comfrey pellet structure of the present invention may further comprise a plurality of antibacterial anti-inflammatory particles 4, and the plurality of antibacterial anti-inflammatory particles 4 may be simultaneously mixed with the plurality of comfrey particles 2 into the matrix. The plurality of antibacterial anti-inflammatory particles 4 may be dispersed in the body 1. The plurality of antibacterial anti-inflammatory particles 4 may be selected from the group consisting of honeysuckle extract particles, angelica extract particles, burdock extract particles, musk extract particles, andrographis extract particles, capillaris extract particles, berberine extract particles, citron extract a group of particles, gentian extract particles, white crane ganoderma lucidum extract particles, dandelion extract particles, turmeric extract particles, licorice extract particles and perilla extract particles, thus, the plurality of antibacterial anti-inflammatory particles 4 The active ingredients of the several comfrey particles 2 can produce a synergistic effect, thereby enhancing the antibacterial and anti-inflammatory action of the comfrey droplet structure.

據由前述結構,由於該數個紫草顆粒2、該數個護眼顆粒3及該數個抗菌消炎顆粒4可以由該本體1包覆,使該數個紫草顆粒2、該數個護眼顆粒3及該數個抗菌消炎顆粒4可以與外界的溫度、空氣、光線、水氣等環境因子隔絕,以減少該數個紫草顆粒2、該數個護眼顆粒3及該數個抗菌消炎顆粒4發生變質等問題,使該數個紫草顆粒2、該數個護眼顆粒3及該數個抗菌消炎顆粒4不易失去保健效果及產生有害物質;此外,由於該數個紫草顆粒2、該數個護眼顆粒3及數個抗菌消炎顆粒4可以分散於該本體1中,該數個紫草顆粒2、該數個護眼顆粒3及數個抗菌消炎顆粒4可以在該本體1溶解後釋出,且溶解狀態的該基質可以減少該數個紫草顆粒2、該數個護眼顆粒3及數個抗菌消炎顆粒4的聚集,使該數個紫草顆粒2及該數個護眼顆粒3及該數個抗菌消炎顆粒4的溶解度可以提升,進而提升人體的可吸收率及生體利用率。According to the foregoing structure, since the plurality of comfrey particles 2, the plurality of eye protection particles 3, and the plurality of antibacterial anti-inflammatory particles 4 can be coated by the body 1, the plurality of comfrey particles 2 and the plurality of rot The eye particles 3 and the plurality of antibacterial anti-inflammatory particles 4 can be isolated from ambient factors such as temperature, air, light, moisture and the like to reduce the plurality of comfrey particles 2, the plurality of eye-protecting particles 3 and the plurality of antibacterial particles The problem of deterioration of the anti-inflammatory particles 4 causes the plurality of comfrey particles 2, the plurality of eye-protecting particles 3, and the plurality of antibacterial anti-inflammatory particles 4 to lose health care effects and produce harmful substances; in addition, due to the plurality of comfrey particles 2, the plurality of eye protection particles 3 and a plurality of antibacterial anti-inflammatory particles 4 may be dispersed in the body 1, the plurality of comfrey particles 2, the plurality of eye protection particles 3 and the plurality of antibacterial anti-inflammatory particles 4 may be in the body Dissolving after dissolving, and the matrix in a dissolved state can reduce aggregation of the plurality of comfrey particles 2, the plurality of eye-protecting particles 3, and the plurality of antibacterial anti-inflammatory particles 4, and the plurality of comfrey particles 2 and the number The solubility of the eye protection particles 3 and the plurality of antibacterial anti-inflammatory particles 4 can be improved. Can enhance the absorption rate and bioavailability of the human body.

請參照第2圖所示,其係本創作紫草滴丸微粒結構的第二實施例,該紫草滴丸微粒結構還可以另包含一外膜層5,該外膜層5可以包覆於該本體1的外表面。藉此,該外膜層5可以使該本體1隔絕於外界的溫度、空氣、光線或水氣等環境因子,而可以減少該本體1發生變質等問題,進而提升該紫草滴丸微粒結構的保存期限。該外層膜5較佳可以由水溶性材料與甜味劑、酸味劑或香料等矯味劑混合形成,如此,該外層膜5可以提升該紫草滴丸微粒結構的氣味及口感,令該紫草滴丸微粒結構可以方便使用者服用。Referring to FIG. 2, which is a second embodiment of the present invention, the comfrey droplet structure may further comprise an outer film layer 5, which may be coated on the outer layer 5 The outer surface of the body 1. Thereby, the outer film layer 5 can isolate the body 1 from ambient factors such as temperature, air, light or moisture, and can reduce the deterioration of the body 1 and the like, thereby improving the structure of the comfrey droplets. Shelf life. The outer layer film 5 is preferably formed by mixing a water-soluble material with a flavoring agent such as a sweetener, a sour agent or a flavoring agent. Thus, the outer layer film 5 can enhance the odor and mouthfeel of the comfrey pellet structure, and the comfrey The dropping pellet structure can be conveniently taken by the user.

綜上所述,本創作的紫草滴丸微粒結構,由於該本體可以包覆該數個紫草顆粒,使該數個紫草顆粒可以與外界的溫度、空氣、光線、水氣等環境因子隔絕,進而可以減少該數個紫草顆粒的活性成分變質等問題的發生,具有提升安定性的功效;另一方面,由於各該紫草顆粒可以為分子顆粒、膠體顆粒或微晶顆粒,且該數個紫草顆粒分散於該本體中,藉此,該數個紫草顆粒可以在該本體溶解後釋出,且溶解狀態的該基質可以減少該數個紫草顆粒的聚集,以維持該數個紫草顆粒的分散狀態,進而增加溶解度,具有提升紫草活性成分的人體吸收率及生體利用率的功效。In summary, the comfrey pellet structure of the present invention can cover the plurality of comfrey particles by the body, so that the plurality of comfrey particles can be combined with environmental factors such as temperature, air, light, moisture and the like. The isolation can further reduce the occurrence of problems such as deterioration of the active ingredients of the plurality of comfrey particles, and has the effect of improving stability; on the other hand, each of the comfrey particles can be molecular particles, colloidal particles or microcrystalline particles, and The plurality of comfrey particles are dispersed in the body, whereby the plurality of comfrey particles can be released after the body is dissolved, and the matrix in a dissolved state can reduce aggregation of the plurality of comfrey particles to maintain the The dispersion state of several comfrey particles, thereby increasing the solubility, has the effect of improving the absorption rate of the active ingredients of the comfrey and the utilization rate of the living body.

雖然本創作已利用上述較佳實施例揭示,然其並非用以限定本創作,任何熟習此技藝者在不脫離本創作之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本創作所保護之技術範疇,因此本創作之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed by the above-described preferred embodiments, it is not intended to limit the present invention, and it is still within the spirit and scope of the present invention to make various changes and modifications to the above embodiments. The technical scope of the protection is created, so the scope of protection of this creation is subject to the definition of the patent application scope attached.

1‧‧‧本體1‧‧‧ Ontology

2‧‧‧紫草顆粒 2‧‧‧ comfrey granules

3‧‧‧護眼顆粒 3‧‧‧ Eye Care Granules

4‧‧‧抗菌消炎顆粒 4‧‧‧Antibacterial anti-inflammatory particles

5‧‧‧外膜層 5‧‧‧ outer membrane

[第1圖] 本創作第一實施例的結構剖視圖。 [第2圖] 本創作第二實施例的結構剖視圖。 [Fig. 1] A cross-sectional view showing the structure of a first embodiment of the present invention.  [Fig. 2] A cross-sectional view showing the structure of the second embodiment of the present invention.  

Claims (4)

一種紫草滴丸微粒結構,包含: 一本體;及 數個紫草顆粒,各該紫草顆粒由該本體包覆,使該數個紫草顆粒分散於該本體中,各該紫草顆粒為包含紫草活性成分的分子顆粒、膠體顆粒或微晶顆粒。 A comfrey drip pellet structure comprising:  An ontology; and  a plurality of comfrey particles, each of which is coated with the body, so that the plurality of comfrey particles are dispersed in the body, and each of the comfrey particles is a molecular particle, a colloidal particle or a microcrystal comprising an active ingredient of comfrey Particles.   如申請專利範圍第1項所述之紫草滴丸微粒結構,另包含數個護眼顆粒,該數個護眼顆粒選自由一維生素A顆粒、一葉黃素顆粒、一玉米黃素顆粒、一蝦紅素顆粒、一藻紅素顆粒、一茄紅素顆粒、一花青素顆粒、一黑醋粟萃取物顆粒、一小米草萃取物顆粒、一山桑子萃取物顆粒、一黃耆萃取物顆粒、一決明子萃取物顆粒、一菊花萃取物顆粒及一枸杞萃取物顆粒所組成之群組。The comfrey pellet structure according to claim 1, further comprising a plurality of eye protection particles selected from the group consisting of a vitamin A particle, a lutein granule, a zeaxanthin granule, and a Astaxanthin particles, phycoerythrin particles, a lycopene granule, anthocyanin granules, a black vinegar extract granule, a millet grass extract granule, a mulberry extract granule, a scutellaria extract A group consisting of granules, cassia seed extract granules, a chrysanthemum extract granule, and a sputum extract granule. 如申請專利範圍第1項所述之紫草滴丸微粒結構,其中,另包含數個抗菌消炎顆粒,該數個抗菌消炎顆粒選自由一金銀花萃取物顆粒、一當歸萃取物顆粒、一牛蒡萃取物顆粒、一藿香萃取物顆粒、一穿心蓮萃取物顆粒、一茵陳萃取物顆粒、一黃連萃取物顆粒、一香薷萃取物顆粒、一龍膽草萃取物顆粒、一白鶴靈芝草萃取物顆粒、一蒲公英萃取物顆粒、一薑黃萃取物顆粒、一甘草萃取顆粒及一紫蘇萃取物顆粒所組成之群組。The comfrey drip pellet structure according to claim 1, wherein the plurality of antibacterial anti-inflammatory particles are selected from the group consisting of a honeysuckle extract granule, an angelica extract granule, and a calf Extract granules, a musk extract granules, an andrographis extract granules, a sinensis extract granule, a berberine extract granule, a citron extract granule, a gentian extract granule, a white crane ganoderma lucidum extract A group consisting of granules, a dandelion extract granule, a turmeric extract granule, a licorice extract granule, and a perilla extract granule. 如申請專利範圍第1至3項中任一項所述之紫草滴丸微粒結構,另包含一外膜層,該外膜層包覆於該本體的外表面。The comfrey pellet structure according to any one of claims 1 to 3, further comprising an outer film layer coated on an outer surface of the body.
TW108203661U 2019-03-26 2019-03-26 Comfrey dripping pill particle structure TWM582394U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108203661U TWM582394U (en) 2019-03-26 2019-03-26 Comfrey dripping pill particle structure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108203661U TWM582394U (en) 2019-03-26 2019-03-26 Comfrey dripping pill particle structure

Publications (1)

Publication Number Publication Date
TWM582394U true TWM582394U (en) 2019-08-21

Family

ID=68317835

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108203661U TWM582394U (en) 2019-03-26 2019-03-26 Comfrey dripping pill particle structure

Country Status (1)

Country Link
TW (1) TWM582394U (en)

Similar Documents

Publication Publication Date Title
Arenas-Jal et al. An overview of microencapsulation in the food industry: Opportunities, challenges, and innovations
CN1326517C (en) Process for preparing dry extracts
Rocha et al. Microencapsulation by atomization of the mixture of phenolic extracts
ES2732833T3 (en) Microencapsulation of bioactive substances and methods of obtaining it
US6689388B2 (en) Microencapsulated delivery system for high viscosity fluids
CN105326649B (en) One kind discoloration capsule
ES2598482T3 (en) Improved enzyme formulations for feed
JP4463801B2 (en) Method for producing a powder preparation of a fat-soluble substance
CN102573496A (en) Slow release magnesium composition and uses thereof
US20070254070A1 (en) Encapsulating Plant Extracts Adsorbed and/or Absorbed in Precipitated Silica
CN105263480A (en) Enteric coated multiparticulate controlled release peppermint oil composition and related methods
ES2920153T3 (en) Lycopene microcapsule powder and preparation method therefor
WO2017002803A1 (en) Composition for outer layer of solid preparation, and easy-to-take solid preparation including said composition for outer layer
CN105533713A (en) Medical food with anti-ageing function and preparation method of medical food
JP2008516618A (en) Coloring of feed products and veterinary drugs
TWM582394U (en) Comfrey dripping pill particle structure
KR101326376B1 (en) Cosmetic Compositon Using Nano Capsule Containing Azelaic Acid And Skim Milk for Treating Acne Skin and Its Manufacturing Method Thereof
EP2386296B1 (en) New application forms for cineol
CN108882722A (en) Release vitamin and mineral on time in edible oil
CN107929327B (en) A kind of manufacture craft improving ox toad granule stability
CN103409001A (en) Pearly-lustre type coating premix and preparation method thereof
CA3188619A1 (en) Pharmaceutical compositions for improved delivery of therapeutic lipophilic actives
WO2020175894A2 (en) Multi-coated soft capsule
TW201827035A (en) Multi-layered microcapsule and manufacturing method thereof
CN106511125A (en) Eupatorium fortunei turcz compound solid-state essential oil and uses thereof, eupatorium fortunei turcz compound solid-state essential oil capsule preparation method